Sutro Biopharma STRO Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $73.68M+26.8% | $58.13M-11.8% | $65.93M+3.0% | $64.03M-39.7% | $106.23M-44.2% | ||
| $128.88M+54.7% | $83.3M-18.1% | $101.67M-27.9% | $141.11M-1.1% | $142.74M+12.8% | ||
| $858K0.0% | $858K0.0% | $858K0.0% | $858K0.0% | $858K0.0% | ||
| $12.48M+214% | $3.98M+1.4% | $3.92M-51.0% | $8M-41.0% | $13.56M+57.4% | ||
| $5.93M+7.4% | $5.52M-47.9% | $10.6M-42.7% | $18.5M-25.6% | $24.88M+39.8% | ||
| $220.97M+46.4% | $150.93M-17.1% | $182.11M-21.4% | $231.63M-19.4% | $287.41M-16.3% | ||
| $9.36M-12.1% | $10.65M-20.2% | $13.35M-10.9% | $14.98M-10.8% | $16.8M-7.7% | ||
| $9.71M-11.0% | $10.9M-18.3% | $13.34M-10.1% | $14.84M-8.9% | $16.28M-7.9% | ||
| $1.09M+120% | $495K— | $0-100% | $50K-41.2% | $85K-98.8% | ||
| $241.99M+39.2% | $173.83M-17.1% | $209.66M-20.1% | $262.36M-18.4% | $321.43M-17.0% | ||
| $5.49M-27.5% | $7.57M+7.5% | $7.03M+63.3% | $4.31M-47.3% | $8.18M-21.9% | ||
| $5.35M-63.4% | $14.64M+10.5% | $13.25M+12.6% | $11.76M+1.8% | $11.55M-10.5% | ||
| $9.4M-11.0% | $10.56M+17.7% | $8.98M-25.0% | $11.96M-82.7% | $68.98M-1.2% | ||
| $7.6M-2.4% | $7.78M-2.2% | $7.96M-1.2% | $8.06M+3.8% | $7.77M+3.8% | ||
| $1.23M-39.2% | $2.03M-46.0% | $3.76M-45.6% | $6.91M-19.4% | $8.57M-31.7% | ||
| $70.81M-5.8% | $75.13M+4.5% | $71.9M-3.2% | $74.25M-44.2% | $133.05M+0.9% | ||
| $6.03M-23.6% | $7.89M-18.7% | $9.7M-15.9% | $11.54M-15.4% | $13.63M-13.0% | ||
| $13.63M-13.0% | $15.67M-11.3% | $17.66M-9.9% | $19.59M-8.4% | $21.4M-7.6% | ||
| $1.69M0.0% | $1.69M0.0% | $1.69M0.0% | $1.69M0.0% | $1.69M0.0% | ||
| $308.88M+0.8% | $306.28M+3.2% | $296.93M+0.8% | $294.47M-15.2% | $347.24M+1.4% | ||
| $17K+88.9% | $9K-89.4% | $85K0.0% | $85K+1.2% | $84K+950% | ||
| $949.64M+12.3% | $845.48M+0.2% | $843.81M+0.2% | $842.15M+0.6% | $836.95M+0.7% | ||
| -$1.02B-3.9% | -$977.96M-5.0% | -$931.19M-6.5% | -$874.34M-1.3% | -$862.84M-9.7% | ||
| -$101K-632% | $19K-42.4% | $33K+354% | -$13K-44.4% | -$9K-123% | ||
| -$66.89M+49.5% | -$132.45M-51.8% | -$87.27M-172% | -$32.11M-24.4% | -$25.81M-158% | ||
| $241.99M+39.2% | $173.83M-17.1% | $209.66M-20.1% | $262.36M-18.4% | $321.43M-17.0% | ||
| $128.88M+54.7% | $83.3M-18.1% | $101.67M-27.9% | $141.11M-1.1% | $142.74M+12.8% | ||
| $1.09M+120% | $495K— | $0-100% | $50K-41.2% | $85K-98.8% | ||
| $9.71M-11.0% | $10.9M-18.3% | $13.34M-10.1% | $14.84M-8.9% | $16.28M-7.9% | ||
| $9.71M-11.0% | $10.9M-18.3% | $13.34M-10.1% | $14.84M-8.9% | $16.28M-7.9% | ||
| $1.09M+120% | $495K— | $0-100% | $50K-41.2% | $85K-98.8% | ||
| $9.71M-11.0% | $10.9M-18.3% | $13.34M-10.1% | $14.84M-8.9% | $16.28M-7.9% | ||
| $1.09M+120% | $495K— | $0-100% | $50K-41.2% | $85K-98.8% | ||
| $1.23M-39.2% | $2.03M-46.0% | $3.76M-45.6% | $6.91M-19.4% | $8.57M-31.7% | ||
| $5.35M-63.4% | $14.64M+10.5% | $13.25M+12.6% | $11.76M+1.8% | $11.55M-10.5% | ||
| $42.97M+24.3% | $34.58M-0.3% | $34.68M-9.1% | $38.15M+4.3% | $36.57M+17.0% | ||
| $5.35M-63.4% | $14.64M+10.5% | $13.25M+12.6% | $11.76M+1.8% | $11.55M-10.5% | ||
| $1.23M-39.2% | $2.03M-46.0% | $3.76M-45.6% | $6.91M-19.4% | $8.57M-31.7% | ||
| $1.23M-39.2% | $2.03M-46.0% | $3.76M-45.6% | $6.91M-19.4% | $8.57M-31.7% | ||
| $13.63M-13.0% | $15.67M-11.3% | $17.66M-9.9% | $19.59M-8.4% | $21.4M-7.6% | ||
| $949.64M+12.3% | $845.48M+0.2% | $843.81M+0.2% | $842.15M+0.6% | $836.95M+0.7% | ||
| $17K+88.9% | $9K-89.4% | $85K0.0% | $85K+1.2% | $84K+950% | ||
| $229.11M+4.4% | $219.54M+4.6% | $209.88M+4.9% | $200.08M+5.1% | $190.3M+5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sutro Biopharma's total assets?
- Sutro Biopharma (STRO) holds $242.0M in total assets, down 24.7% year over year.
- How much debt does Sutro Biopharma have?
- Sutro Biopharma carries $13.6M in total debt against -$66.9M of shareholders' equity, a debt-to-equity ratio of 0.52.
- How much cash does Sutro Biopharma have?
- Sutro Biopharma holds $73.7M in cash and equivalents.
- Can Sutro Biopharma cover its short-term obligations?
- Its current ratio is 3.12 — current assets exceed current liabilities.
- Where does Sutro Biopharma's balance sheet data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
